HomeOwner SearchCategory Search
Visit USCOInflammation and Retinal Disease: Compliment Biology and Pathology, Editor John D. Lambris
Text Registration
Copyright Title
Inflammation and Retinal Disease: Compliment Biology and Pathology, Editor John D. Lambris
Status
Published
on 10 Sept 2010
Year of Creation
2010
Copyright Claimant
Springer Science+Business Media, LLC
Registration Number
TX0007231664
on 10 Sept 2010Copyright Summary
The U.S. Copyright record (Registration Number: TX0007231664) dated 10 Sept 2010, pertains to an electronic file (eService) titled "Inflammation and Retinal Disease: Compliment Biology and Pathology, Editor John D. Lambris" created in 2010. The copyright holder is Springer Science+Business Media, LLC, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Springer Science+Business Media, LLC.
Application Details
Registration Number
TX0007231664
Registration Date
9/10/2010
Year of Creation
2010
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Springer Science+Business Media, LLC
Physical Description
Book, 167 p
First Publication Nation
United States
ISBN
978-1-4419-5634-7
Statements
Application Title Statement: Inflammation and Retinal Disease: Compliment Biology and Pathology, Editor John D. Lambris
Author Statement: Springer Science+Business Media, LLC employer for hire Domicile: not known Citizenship: not known Authorship: text, editing
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.